These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 31628997

  • 1. Co-encapsulation of superparamagnetic nanoparticles and doxorubicin in PLGA nanocarriers: Development, characterization and in vitro antitumor efficacy in glioma cells.
    Luque-Michel E, Sebastian V, Larrea A, Marquina C, Blanco-Prieto MJ.
    Eur J Pharm Biopharm; 2019 Dec; 145():65-75. PubMed ID: 31628997
    [Abstract] [Full Text] [Related]

  • 2. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
    Shirvalilou S, Khoei S, Khoee S, Raoufi NJ, Karimi MR, Shakeri-Zadeh A.
    Chem Biol Interact; 2018 Nov 01; 295():97-108. PubMed ID: 30170108
    [Abstract] [Full Text] [Related]

  • 3. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
    Metin E, Mutlu P, Gündüz U.
    Anticancer Agents Med Chem; 2018 Nov 01; 18(8):1138-1147. PubMed ID: 29532763
    [Abstract] [Full Text] [Related]

  • 4. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
    Mosafer J, Teymouri M, Abnous K, Tafaghodi M, Ramezani M.
    Mater Sci Eng C Mater Biol Appl; 2017 Mar 01; 72():123-133. PubMed ID: 28024568
    [Abstract] [Full Text] [Related]

  • 5. Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy.
    Pang L, Zhu Y, Qin J, Zhao W, Wang J.
    Drug Deliv; 2018 Nov 01; 25(1):1922-1931. PubMed ID: 30465444
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma.
    Shen C, Wang X, Zheng Z, Gao C, Chen X, Zhao S, Dai Z.
    Int J Nanomedicine; 2019 Nov 01; 14():101-117. PubMed ID: 30587988
    [Abstract] [Full Text] [Related]

  • 8. High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy.
    Peng N, Wu B, Wang L, He W, Ai Z, Zhang X, Wang Y, Fan L, Ye Q.
    Biomater Sci; 2016 Nov 15; 4(12):1802-1813. PubMed ID: 27792228
    [Abstract] [Full Text] [Related]

  • 9. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation.
    Godara S, Lather V, Kirthanashri SV, Awasthi R, Pandita D.
    Mater Sci Eng C Mater Biol Appl; 2020 Apr 15; 109():110576. PubMed ID: 32228957
    [Abstract] [Full Text] [Related]

  • 10. Lipid/PLGA Hybrid Microbubbles as a Versatile Platform for Noninvasive Image-Guided Targeted Drug Delivery.
    Chen Y, Liang Y, Jiang P, Li F, Yu B, Yan F.
    ACS Appl Mater Interfaces; 2019 Nov 13; 11(45):41842-41852. PubMed ID: 31633326
    [Abstract] [Full Text] [Related]

  • 11. Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles.
    Liu P, Chen N, Yan L, Gao F, Ji D, Zhang S, Zhang L, Li Y, Xiao Y.
    Carbohydr Polym; 2019 Jun 01; 213():17-26. PubMed ID: 30879657
    [Abstract] [Full Text] [Related]

  • 12. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
    Wang J, Wang F, Li X, Zhou Y, Wang H, Zhang Y.
    Colloids Surf B Biointerfaces; 2019 May 01; 177():425-432. PubMed ID: 30798063
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J, Abnous K, Tafaghodi M, Mokhtarzadeh A, Ramezani M.
    Eur J Pharm Biopharm; 2017 Apr 01; 113():60-74. PubMed ID: 28012991
    [Abstract] [Full Text] [Related]

  • 14. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
    Shen X, Li T, Chen Z, Geng Y, Xie X, Li S, Yang H, Wu C, Liu Y.
    Int J Nanomedicine; 2017 Apr 01; 12():4299-4322. PubMed ID: 28652734
    [Abstract] [Full Text] [Related]

  • 15. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.
    Shafiei-Irannejad V, Samadi N, Salehi R, Yousefi B, Rahimi M, Akbarzadeh A, Zarghami N.
    Pharm Res; 2018 Apr 18; 35(6):119. PubMed ID: 29671072
    [Abstract] [Full Text] [Related]

  • 16. Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery.
    Jia Y, Yuan M, Yuan H, Huang X, Sui X, Cui X, Tang F, Peng J, Chen J, Lu S, Xu W, Zhang L, Guo Q.
    Int J Nanomedicine; 2012 Apr 18; 7():1697-708. PubMed ID: 22619520
    [Abstract] [Full Text] [Related]

  • 17. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
    Mao J, Meng X, Zhao C, Yang Y, Liu G.
    Anticancer Drugs; 2019 Jul 18; 30(6):604-610. PubMed ID: 30855310
    [Abstract] [Full Text] [Related]

  • 18. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y, Mao K, Zhang B, Zhao Y.
    Mater Sci Eng C Mater Biol Appl; 2017 Jan 01; 70(Pt 1):763-771. PubMed ID: 27770953
    [Abstract] [Full Text] [Related]

  • 19. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
    Lin R, Shi Ng L, Wang CH.
    Biomaterials; 2005 Jul 01; 26(21):4476-85. PubMed ID: 15701377
    [Abstract] [Full Text] [Related]

  • 20. Na+/K+ ATPase-targeted delivery to metastatic breast cancer models.
    Araste F, Abnous K, Hashemi M, Dehshahri A, Detampel P, Alibolandi M, Ramezani M.
    Eur J Pharm Sci; 2020 Feb 15; 143():105207. PubMed ID: 31870814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.